A Dose-escalation Study of BIBF 1120 in Japanese Patients With Advanced Solid Tumours
Clinical trial NCT02182128 · COMPLETED
Trial details
- NCT number
- NCT02182128
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2009-06-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.